Overview

A Study of Ustekinumab in Pediatric Participants With Active Juvenile Psoriatic Arthritis

Status:
Not yet recruiting
Trial end date:
2026-03-10
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the pharmacokinetics (PK) and efficacy of ustekinumab in juvenile psoriatic arthritis (jPsA).
Phase:
Phase 3
Details
Lead Sponsor:
Janssen Research & Development, LLC
Treatments:
Ustekinumab